益生菌酸奶对儿科患者抗生素相关腹的影响;随机对照试验
Rajesh Shyoran1, Amanjot Kaur2, Pareek Bharat3
1Department of Child Health Nursing, SPHE College of Nursing, Gharuan, Mohali, Punjab, India.
Journal of education and health promotion
|October 21, 2024
概括
益生菌酸奶显著减少了儿童的抗生素相关腹 (AAD). 这种简单的干预提供了一种具有成本效益的方法来预防儿科患者这种常见的副作用.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 微生物组研究 微生物组研究
- 临床营养学 临床营养学
背景情况:
- 抗生素相关性腹 (AAD) 是小儿患者抗生素治疗的常见副作用.
- 益生菌酸奶为AAD预防提供了益生菌囊的潜在成本效益和可访问的替代品.
研究的目的:
- 评估益生菌酸奶在预防住院儿科患者抗生素相关腹 (AAD) 的疗效.
- 评估益生菌酸奶对腹发病率和严重性的影响.
主要方法:
- 进行了一项随机对照试验,其中244名接受抗生素治疗的儿科患者.
- 患者被分配到益生菌酸奶干预组 (n=122) 或标准护理对照组 (n=122).
- 在第五天评估了腹发病率和严重程度;遵循CONSORT指南.
主要成果:
- 与对照组 (36.88%) 相比,益生菌酸奶组 (13.90%) 的AAD发病率明显较低 (p=0.001).
- 益生菌酸奶改善了便的一致性,减少了腹的持续时间和频率,减少了急性,腹部不适和脱水 (p ≤ 0.001).
结论:
- 益生菌酸奶是儿童患者抗生素相关腹的有效预防措施.
- 医疗保健提供者,特别是执业护士,应该考虑益生菌酸奶作为一个有价值的工具,以减轻这种常见的抗生素副作用.
相关概念视频
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
109
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
109
Drugs for Treatment of Diarrhea-Predominant IBS
149
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
149
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
322
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
322
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
328
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
328


